Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa

Journal of Dermatological Treatment

Volumn 12, Issue 3, 2001, Pages 167-169

  Ozdag, F ^a   Akar, A ^a   Eroglu, E ^a   Erbil, H ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Interferons; Lichen myxedematosus; Papular mucinosis; Rhabdomyolysis; Scleromyxedema

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; MELPHALAN; PREDNISOLONE; RETINOID;

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; MALE; MYXEDEMA; PRIORITY JOURNAL; PUNCH BIOPSY; PUVA; RHABDOMYOLYSIS; SCLEROMYXEDEMA; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; HUMANS; INTERFERON-ALPHA; LICHENOID ERUPTIONS; MALE; MUCINOSES; MYXEDEMA; RHABDOMYOLYSIS;

EID: 0035200021     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630152607916     Document Type: Article

References (10)

1. Scleromyxedema
2. Scleromyxedema treatment with interferon alfa
3. Persistence of a reduced collagenproducing phenotype in cultured scleroderma fibroblasts after short term exposure to interferons
4. Fatal rhabdomyolysis and multiple organ failure associated with interferon alfa in malign melanoma
5. Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma
6. Rhabdomyolysis after treatment with interferon alfa
7. Scleromyxedema myopathy: Case report and review of the literature
8. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis)
9. Scleromyxedema and severe myositis
10. Parodoxical effect of interferon alfa on lichen myxedematosus